categories
HOT TOPICS
- The Accelerator Conundrum
- The Startup Velocity Question
- Platform as a Service
- Man and Superman
- Web 3.0 = (4C + P + VS)
- The Future: End of Capitalism
- Capitalism 2.0
xevant
Thought Leaders in Healthcare IT: Brandon Newman, CEO of Xevant (Part 3)
Sramana Mitra: What are you learning? What are the key areas of leakage? Brandon Newman: We have a couple of observations. The obvious learning that we expected is there. These include an opportunity to switch utilization, go to a lower-cost medication, or help manage members.
Thought Leaders in Healthcare IT: Brandon Newman, CEO of Xevant (Part 2)
Brandon Newman: Drugs are becoming a highly prevalent part of the overall delivery of healthcare. It has become the focus. For example, these health plans that help manage $500 million are going to enable dozens of new specialty biologic medications come to market that is not going to cost your stereotypical couple of hundred dollars.
Thought Leaders in Healthcare IT: Brandon Newman, CEO of Xevant (Part 1)
Brandon talks about unlocking savings related to expensive versus affordable drugs. Sramana Mitra: Let’s start by introducing our audience to yourself and Xevant.
